About Seppic
Seppic is a company based in Paris (France) founded in 1943. The company has 12 employees as of April 07, 2024. Seppic has completed 1 acquisition, including EPI France. Seppic operates in a competitive market with competitors including Novartis, Catalent, Surrozen, Biotage and Curia, among others.
- Headquarter Paris, France
- Employees 12 as on 07 Apr, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Seppic Speciality Ingredients Private Limited
- Date of Incorporation 05 Aug, 2019
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$535.89 K (USD)17.65as on Mar 31, 2023
-
Net Profit
$68.3 K (USD)123.14as on Mar 31, 2023
-
EBITDA
$58.4 K (USD)16.98as on Mar 31, 2023
-
Latest Funding Round
$202.82 K (USD), Grant
May 01, 2021
- Investors
-
Employee Count
12
as on Apr 07, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Seppic
Unlock access to complete
Software Development Team
28 people
Sales and Marketing
16 people
Finance and Accounting
5 people
Human Resources and Administration
5 people
Leadership Team
5 people
Head Team
4 people
Product Management Team
3 people
R Team
2 people
Unlock access to complete
Funding Insights of Seppic
Investors in Seppic
Seppic has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Seppic
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Seppic
Seppic has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include EPI France.
Investment portfolio details for Seppic
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
CDMO focused on manufacturing of APIs for cosmetics and nutritional supplement markets
|
Locked | Locked | 1997 | Locked |
Complete acquisition details for Seppic
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Seppic
Detailed financials for Seppic
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Seppic Comparisons
Peer comparison for Seppic
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Seppic
Seppic operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novartis, Catalent, Surrozen, Biotage and Curia, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
R&D focused on manufacturing of drugs for multiple therapeutic areas
|
|
| Locked | Locked | Locked |
CDMO offering drug and biologics development services
|
|
| Locked | Locked | Locked |
Selective Wnt agonists are developed for human tissue regeneration.
|
|
| Locked | Locked | Locked |
Organic synthesis, analytical, and peptide chemistry services for drug discovery and development
|
|
| Locked | Locked | Locked |
Drug research, development, testing, and consulting services are provided.
|
|
| Locked | Locked | Locked |
Provides contract research, development, and manufacturing services for biologic drugs.
|
Detailed competitors of Seppic
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Seppic
Complete news archive for Seppic
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Seppic
Seppic was founded in 1943 and raised its 1st funding round 78 years after it was founded.
Seppic is headquartered in Paris, France.
As of Apr 07, 2024, the latest employee count at Seppic is 12.
Annual revenue of Seppic is $535.89K as on Mar 31, 2023.
Seppic was founded in 1943 and is headquartered in Paris, France. Operations are centered on the production of pharmaceuticals, dietary supplements, and beauty care items, along with related products. The company serves the health, nutrition, and cosmetics sectors through its manufacturing processes. Activities are conducted primarily in Europe, with a focus on formulation and supply for industrial applications in these fields.
Seppic has made 1 acquisition, including EPI France.
Seppic has 1 investor. Key investors include European Union.